Immediate Impact

3 from Science/Nature 66 standout
Sub-graph 1 of 24

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
2 intermediate papers

Works of Andrew Lipsky being referenced

Managing toxicities of Bruton tyrosine kinase inhibitors
2020
Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study
2014

Author Peers

Author Last Decade Papers Cites
Andrew Lipsky 549 390 200 251 23 671
Małgorzata Wach 545 429 212 191 34 667
Marie‐Sarah Dilhuydy 365 322 133 244 29 590
Sandra Kanan 518 460 167 287 23 743
A. M. Liberati 464 352 193 155 19 670
Saad M. B. Rassam 483 446 135 283 15 670
Tawfiq Henni 268 319 201 217 26 670
Sasanka M. Handunnetti 535 482 165 148 23 712
Indu Lal 493 325 355 276 14 746
Dimitra Anagnostou 247 300 176 131 39 678
Elizabeth Bilotti 573 451 378 202 29 814

All Works

Loading papers...

Rankless by CCL
2026